| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.004 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |